Ikena Oncology, Inc.

Ikena Oncology, Inc.verified

IKNA

Price:

$17.16

Market Cap:

$718.82M

Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-175, an oral inhibitor of aryl hydrocarbon receptor; and IK-007, an oral selective EP4 receptor antagonist for the treatment of microsatellite stable colorectal cancer. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts...[Read more]

Industry

Biotechnology

IPO Date

2021-03-26

Stock Exchange

NASDAQ

Ticker

IKNA

The Current Ratio as of November 2025 (TTM) for Ikena Oncology, Inc. (IKNA) is 13.52

According to Ikena Oncology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 13.52. This represents a change of 0.25% compared to the average of 13.49 of the last 4 quarters.

Ikena Oncology, Inc. (IKNA) Historical Current Ratio (quarterly & annually)

How has IKNA Current Ratio performed in the past?

The mean historical Current Ratio of Ikena Oncology, Inc. over the last ten years is 7.87. The current 13.52 Current Ratio has changed 17.07% with respect to the historical average. Over the past ten years (40 quarters), IKNA's Current Ratio was at its highest in in the June 2024 quarter at 18.22. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

7.87

Median

7.44

Minimum

3.51

Maximum

12.58

Ikena Oncology, Inc. (IKNA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Ikena Oncology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 69.02%

Maximum Annual Current Ratio = 12.58

Minimum Annual Increase = -32.88%

Minimum Annual Current Ratio = 3.51

Quarterly (TTM)
Annual
YearCurrent RatioChange
202411.80-6.19%
202312.5869.02%
20227.44-14.46%
20218.7048.50%
20205.8667.05%
20193.51-32.88%

Ikena Oncology, Inc. (IKNA) Average Current Ratio

How has IKNA Current Ratio performed in the past?

The current Current Ratio of Ikena Oncology, Inc. (IKNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

10.61

5-year avg

9.27

10-year avg

7.87

Ikena Oncology, Inc. (IKNA) Current Ratio vs. Peers

How is IKNA’s Current Ratio compared to its peers?

Ikena Oncology, Inc.’s Current Ratio is greater than ASLAN Pharmaceuticals Limited (1.84), greater than Exscientia plc (4.54), less than Icosavax, Inc. (16.24), greater than Avid Bioservices, Inc. (1.30), greater than Chimerix, Inc. (5.70), greater than Sage Therapeutics, Inc. (9.16), greater than Intercept Pharmaceuticals, Inc. (2.35), greater than Invivyd, Inc. (2.47), greater than iTeos Therapeutics, Inc. (7.53), greater than Niagen Bioscience Inc (3.88),

Build a custom stock screener for Ikena Oncology, Inc. (IKNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ikena Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ikena Oncology, Inc. (IKNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ikena Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Ikena Oncology, Inc.'s Current Ratio?

How is the Current Ratio calculated for Ikena Oncology, Inc. (IKNA)?

What is the highest Current Ratio for Ikena Oncology, Inc. (IKNA)?

What is the 3-year average Current Ratio for Ikena Oncology, Inc. (IKNA)?

What is the 5-year average Current Ratio for Ikena Oncology, Inc. (IKNA)?

How does the current Current Ratio for Ikena Oncology, Inc. (IKNA) compare to its historical average?